NNE Pharmaplan Expands Its Activities In France
Recently NNE Pharmaplan announced the official opening of its new office in Lyon, expanding the company's presence in France and meeting the needs of a growing and dynamic French market. The Lyon office complements NNE Pharmaplan's existing office in Chartres, south-west of Paris, which was established in 2004.
France is one of the world's largest markets for the life science industry and a key strategic region in NNE Pharmaplan's pursuit of strengthening its global position as the leading international supplier of engineering and consulting services to the pharma and biotech industries.
"With the opening of the office in Lyon we join both existing and potential new clients in one of the fastest-growing regions in Europe for biotech investments. This is a great opportunity for us to widen our local presence and expand our portfolio in a very interesting market. I am confident that, with our investments in Lyon, we will see the French market play an increasingly important role for us in the coming years," said Hans Ole Voigt, NNE Pharmaplan CEO.
In 2007, following NNE's acquisition of Pharmaplan, the merged NNE Pharmaplan grouped its French activities in Chartres and created a strong local organisation with increased market strength and greater access to new customers.
During the next 4-5 years the new office in Lyon is expected to contribute significantly to the total turnover generated from NNE Pharmaplan's clients in France.
About NNE Pharmaplan
NNE Pharmaplan is the world's leading engineering and consulting company focused exclusively on the pharma and biotech industries. NNE Pharmaplan covers the entire pharmaceutical supply chain from product development to manufacturing with know-how, expertise and well-proven solutions founded on more than 80 years of experience in the life science industry. Headquartered in Denmark, NNE Pharmaplan employs more than 1500 people at over 20 locations around the world, offering global reach and local knowledge in all major pharma and biotech markets. NNE Pharmaplan is a company in the Novo Group.
For more information visit www.nnepharmaplan.com
SOURCE: NNE Pharmaplan